Companies: 10,795·Total market cap: $144.5T

XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

XTLBNASDAQHealthcare● Active

$2.23

+$0.17(+8.25%)

Market Cap$5275304

P/E Ratio—

52W High$10.28

52W Low$2.02

Avg Volume1.9M

Open$2.27

Beta0.56

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

XTL Biopharmaceuticals Ltd.（XTLB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · XTLB · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-11.52Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)451000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding105,163Shares outstanding history

Next EarningsTBAEarnings history

探索 XTL Biopharmaceuticals Ltd. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-9.60

财务快照

FY 2024Revenue$451000.00

202220232024

FY 2024Net Income-$1.0M▼ 57531.87% YoY

202220232024

FY 2024EPS$-9.60

202220232024

TTM:Revenue: $451000.00Net Income: -$1.0MEPS: $-11.52View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$2.23Current

$—Avg Target

$—High

合计: 2 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

XTL Biopharmaceuticals Ltd.

$2.23+8.25%$5.3M #2

AIM ImmunoTech Inc.

$0.52+0.60%$1.8M #3

Cyclerion Therapeutics, Inc.

$3.01+1.01%$13.0M #4

Ensysce Biosciences, Inc.

$0.25-0.43%$2.3M #5

$2.29+11.17%$50.2M #6

Pasithea Therapeutics Corp.

$0.58-1.61%$4.3M

股票表现

1D+1.46%

1W-9.52%

1M-17.72%

3M-28.18%

YTD-9.91%

1Y-58.20%

5Y-85.61%

关于 XTL Biopharmaceuticals Ltd.

CEONoam Band

IPO DateSep 1, 2005

Employees10

CountryIL

Websitextlbio.com

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to…

Biotechnology HealthcareNASDAQADRIL

关于股票概览与关键数据

XTL Biopharmaceuticals Ltd.（XTLB）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 1, 2005 在 NASDAQ 上市。截至最近交易日，XTLB 股价为 $2.23，市值约为 $5.3M。过去12个月累计回报 -58.20%，年初至今回报 -9.91%。

根据 2 位华尔街分析师，XTL Biopharmaceuticals Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2024 财年 XTL Biopharmaceuticals Ltd. 营收 $451000.00，净利润 -$1.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，XTL Biopharmaceuticals Ltd.（XTLB）股价为 $2.23，在 NASDAQ 上市，52周区间为 $2.02 – $10.28。

XTLB 最新股价XTLB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议